Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ianthus Capital Holdings Inc C.IAN

Alternate Symbol(s):  ITHUF

Healthcare Cannabis
iAnthus Capital Holdings, Inc. is a vertically integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities. The Company is also a developer, producer, and distributor of branded cannabis and cannabidiol (CBD) products in the United States. Through its subsidiaries, the Company owns and/or operates 37 dispensaries and eight cultivation and/or processing facilities in seven United States. Its multi-state operations encompass a full range of medical and adult-use cannabis enterprises, including cultivation, processing, product development, wholesale-distribution, and retail. The Company offers various cannabis products, which includes flower and trim, products containing cannabis flower and trim, such as packaged flower and pre-rolls; cannabis infused products, such as topical creams and edibles and products containing cannabis extracts, such as vape cartridges, concentrates, live resins, wax products, oils, and tinctures.


CSE:IAN - Post by User

Ianthus Capital Holdings Inc > MPX once converted
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by Mike411Ontarioon Jan 10, 2019 10:28am
102 Views
Post# 29211873

RE:RE:MPX once converted

RE:RE:MPX once converted
I copied this from a news letter and it makes sense;
 
By our estimation, the market is valuing MedMen at US$2.4 billion.

         It’s valuing Curaleaf similarly at US$2.9 billion

        iAnthus and MPX combined are trading at nearly a third of these levels.
            
This means that, as investors recognize how much
iAnthus is like the other big cannabis retailers, the stock
price will move a long way to reflect those similarities.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities